Posted on

cbd oil dizziness

One of the most promising benefits is the fact that vaped CBD hits you immediately. Within a matter of seconds, you’ll be able to find relief.

There are many conditions that can cause vertigo. Illnesses, medications, and environmental stimuli can all lead to the symptoms of vertigo: an uncontrollable sensation of dizziness and loss of balance.

CBD For Vertigo Symptoms

This means you can enjoy the benefits of CBD without running the risk of getting intoxicated. This is ideal if you often struggle with vertigo at work or school, or while you’re driving.

While this doesn’t prove that CBD may be reliable for fighting nausea, it’s certainly a suggestion that more research in this area is necessary.

Nausea, vomiting, and dizziness are symptoms that commonly occur alongside one another. This may be one reason that people have reported relief when using CBD for dizziness.

However, rapid-release forms will release CBD faster, so you may experience both wanted and unwanted effects sooner [76+, 77].

And since tinctures and sprays are directly applied in the mouth, they will quickly reach the salivary glands and cause dry mouth. Mouth sprays may also cause a stinging sensation and even burns, especially if they contain alcohol [9, 78].

If you have a weakened immune system, you should consult your doctor before taking CBD oil. You may need to avoid CBD or take a lower dose.

How to Reduce Your Risk of Side Effects from CBD Oil

Additionally, you may also want to look into balancing your Th1/Th2 immune response. If you have a slightly weaker immune system and are prone to allergies, you are probably Th2-dominant.

If you experience digestive issues from using CBD oil, tell your doctor. He or she may recommend reducing the dose or shifting to another brand.

So, make sure to speak with your doctor before starting on a CBD oil regimen.

First, it is important to remember that CBD oil is considered experimental and investigational and far more clinical studies are needed before we can make any firm conclusions about its supposed benefits [1].

McGeeney (2012) suggests that anecdotal evidence suggests that they "are used" by patients for migraine, including as an abortive, and for cluster headache. Baron (2015) also suggests that there is some evidence for a good effect in migraine. As there is some evidence for an effect in chronic pain, one would anticipate a positive effect also in chronic migraine. Thus evidence is currently extremely weak. According to Baron (2018), a chemical called anandamide inhibits dilation of blood vessels, modulates CGRP, and cortical spreading depression. CB1 also inhibits pain responses. We consider this also anecdotal.

There are presently (in 2015) no studies of cannabis for treatment of dizziness, and dizziness appears to be more of a side effect than a therapeutic target (Grotenhermen et al, 2012). Smith (2006) suggested that there are cannabinoid receptors in the central vestibular system. More studies are needed. We have had heard from our patients that they have sometimes had a good response to a non-mind altering component of cannabis (CBD). In theory, this might be related to the anti-seizure effects of some components of cannabis. At this date (early 2018), these are just anecdotes. Products that we have been told were helpful are "Charlotte’s Web", "Watermelon Pucks", and "Anandahemp 200". The first is CBD oil, and can easily be ordered from the internet. The second contains some THC, and is not as readily available. As noted above, THC is approved by the FDA for treatment of nausea and vomiting associated with chemotherapy, and thus it is not surprising that "Watermelon Pucks" might be helpful in some people with dizziness. To be very clear, I am not advocating for these products, but I am simply transmitting what patients are telling me.

As of 2019, cannabis is scheduled to be available for recreational use by early 2020. Presently, In Illinois, the Illinois Compassionate Use of Medical Cannabis Pilot Program requires physicians to certify the diagnosis of a debilitating condition or terminal illness for a qualifying patient seeking to apply for a medical cannabis registry identification card. Whether or not a physician chooses to provide a written physician certification is up to the health care practitioner. More information is here: https://www.dph.illinois.gov/topics-services/prevention-wellness/medical-cannabis/physician-information According to Fife et al (2015), the system used in Illinois is the usual one used to handle the odd situation where the Federal government states that licensed physicians cannot legally prescribe herbal marijuana (although they may prescribe nabilone or dronabinol). Physicians can document that the patient has a medical condition that justifies the use of marijuana under that state’s law. Patients then may proceed to acquire the marijuana, under the particulars of the laws of their state. Nevertheless, certain institutions, including the Department of Veteran affairs, may have policies banning physicians from discussing medical marijuana with their patients. Note that THC can be detected in the urine as long as 12 days after a single "dose". This means that in Illinois, should one be involved in an auto accident, it is theoretically possible to be cited for DUI, 12 days after ingesting a small amount of medical marijuana.

Headache

An individual diagnosed with one or more debilitating conditions is eligible to apply for a medical cannabis registry identification card. The qualifying patient must obtain a written certification from a physician specifying their debilitating condition, unless they are a veteran receiving health services at a VA facility. Veterans must submit one year of medical records from the VA facility where they receive services. Effective January 1, 2015, the Act was amended to include eligibility for children under age 18 and to add seizure disorders to the list of debilitating conditions. On June 30, 2016, the Act was amended (Public Act 099-0519) to add Post-Traumatic Stress Disorder (PTSD) as a debilitating condition and to allow persons diagnosed with a terminal illness to apply for a medical cannabis registry identification card. The Act is effective until Jan, 1, 2020.

Prescription forms of cannabinoids include:

Marijuana is one of the most popular recreational drugs worldwide, and is the #1 illegal drug in the US (followed by cocaine). It is estimated that in the US, about 13.5% of the population uses it every year. (Zhang, 2019) As medical marijuana has become legal in many countries as well as about half of the states in the USA, it is now possible to discuss its use for treatment of common conditions such as dizziness, nausea and headache.

Cannabis is a generic term used for drugs produced from plants belong to the genus Cannabis (i.e. marijuana). Cannabis is not a single substance but rather is a mixture of up to roughly 60 compounds. Some of them, like THC (d-9-tetrahydrocannabinol), are psychoactive, and most others are not.